Inva5b1 Mouse

The mouse exhibits many of the characteristics associated with psoriasis including hyperproliferation of keratinocytes and infiltration of lymphocytes.

Contributors

Inventor Institute
Fiona Watt Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Cat. #: 151442
Research Fields: Cell biology;Genetics
Target: a5 integrin, b1 integrin
disease: Psoriasis
Phenotype: The Inv-a5b1 mouse presents a phenotype very similar to psoriasis, and is an ideal tool for study of the disease in vivo.Abnormal keratinocyte differentiation – widespread thickening of the epidermisKeratinocyte hyperproliferation – flaking epidermis. High numbers of Ki-67 positive cells in all basal and suprabasal layers- Keratin 6 expression in all epidermal layers- Inflammatory skin lesions – dilated capillaries and reddening of skin- Pustules with neutrophil infiltration within or beneath cornified layers – high numbers of CD4 and CD8 lymphocytes within epidermisThere are a number of other psoriasis disease models please see the related page.
Product description: Disease model for psoriasis; in vivo study of human a5 and b1 integrin transgene expression in skin A transgenic mouse expressing integrin a5B1 in the suprabasal layers of the epidermis. The mouse exhibits many of the characteristics associated with psoriasis including hyperproliferation of keratinocytes and infiltration of lymphocytes. Granted patents are associated with this mouse (US6187993 and AU0698317). Alpha5beta1 integrin transgenes under involucrin promoter, giving conditional suprabasal epidermal expression. Psoriasis phenotype
Conditional: Yes
Conditional description: Conditional transgenic
Genetic background: Involucrin-integrin transgene expression constructs were injected into fertilised oocytes from F1 hybrid CBA/C57BL/6 mice. Transgene-positive mice were back-crossed to generate individual founder lines. The a5 transgene founder line was mated to the b1 integrin founder line to generate mice expressing both a5 and b1 integrin transgenes.
Production details: Involucrin-integrin transgene expression constructs were injected into fertilised oocytes from F1 hybrid CBA/C57BL/6 mice. Transgene-positive mice were back-crossed to generate individual founder lines. The a5 transgene founder line was mated to the b1 integrin founder line to generate mice expressing both a5 and b1 integrin transgenes.
Additional notes: The Inv-a5b1 mouse presents a phenotype very similar to psoriasis, and is an ideal tool for study of the disease in vivo. Abnormal keratinocyte differentiation – widespread thickening of the epidermis Keratinocyte hyperproliferation – flaking epidermis. High numbers of Ki-67 positive cells in all basal and suprabasal layers – Keratin 6 expression in all epidermal layers – Inflammatory skin lesions – dilated capillaries and reddening of skin – Pustules with neutrophil infiltration within or beneath cornified layers – high numbers of CD4 and CD8 lymphocytes within epidermis There are a number of other psoriasis disease models please see the related page.
Shipping conditions: Embryo/Spermatoza- Dry Ice
References:

Haase et al. 2001. J Clin Invest. 108(4):527-36. PMID: 11518726.

A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis.

Carroll et al. 1995. Cell. 83(6):957-68. PMID: 8521519.

Carroll et al. 1995. Cell. 83(6):957-68. PMID: 8521519.

Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis.

Related Tools for Mouse models

Cat. # Tool Name
151556 UNG Mouse Key Info View Tool
151444 InvEE Mouse Key Info View Tool
151454 Bmx Cre ERT2 Mouse Key Info View Tool
151519 BRaf1 KI Mouse Key Info View Tool
151549 Inva3b1 Mouse Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.